NCT02194608 Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347) Status COMPLETED Phase NA
NCT02193061 Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs Status COMPLETED Phase PHASE3
NCT02185339 Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics Status COMPLETED Phase PHASE4
NCT02184195 Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy Status COMPLETED Phase PHASE3
NCT02181803 Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) Status COMPLETED Phase PHASE1
NCT02180295 A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014) Status WITHDRAWN Phase PHASE3
NCT02180165 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Status COMPLETED Phase PHASE3
NCT02180061 Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041) Status COMPLETED Phase PHASE1
NCT02179918 A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036) Status COMPLETED Phase PHASE1
NCT02178722 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02174159 Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003) Status COMPLETED Phase PHASE1
NCT02170025 Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients Status TERMINATED Phase PHASE2
NCT02161510 Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002) Status COMPLETED Phase PHASE1
NCT02155335 Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) Status COMPLETED Phase PHASE4
NCT02155322 A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400) Status COMPLETED Phase PHASE2
NCT02146417 Comparison of Low Versus Normal Pressure Pneumoperitoneum - With Profound Low Versus Normal Pressure Pneumoperitoneum -With Profound Muscle Relaxation- During Laparoscopic Donor Nephrectomy Status COMPLETED Phase NA